It is the purpose of this application to evaluate the role of the various monokines in inducing the hypothalamic-pituitary response to infection. We will determine effects of interleukin 1 and interleukin 2 in altering hypothalamic pituitary function and determine whether the effects are mediated directly on the hypothalamus or on the pituitary. We have already performed preliminary experiments with interleukin 1 which indicate that it has a profound effect on the release of GH, TSH and PRL as well as its known capability to stimulate ACTH secretion. We will evaluate the effects of interleukin 2, the newly discovered cachectin, and other monokines as they are obtainable in highly purified or synthetic form, if the actions are mediated via the hypothalamus we will determine whether these are direct actions on the releasing factor neurons or interneurons are involved which then affect the releasing factor neurons via synaptic transmission. We will evaluate the effects on hypothalamic function both in vivo and in vitro and determine which hypothalamic peptide(s) are released. Essentially of particular monokines in bringing about the pattern of release of hypothalamic peptides in infection will be determined by the use developed. The mechanism of the releasing action in the hypothalamus will be investigated by determining the effects of the monokines on the metabolism will be investigated by determining the effects of the monokines on the metabolism of arachidonic acid and by use of suitable antagonists to the active agents in these pathways. Possible direct effects on the pituitary will be evaluated using in vitro incubation of hemipituitaries and dispersed anterior pituitary cells in static and perifusion systems. When such effects are found the mechanism of action will be evaluated. Interactions of the monokines with the various releasing and inhibiting hormones will also be evaluated by incubation of pituitary cells with the monokines in the presence or absence of various doses of these factors. It is hoped that these studies will give a clear understanding of the pathogenesis of the endocrine changes which occur in infectious diseases and that this knowledge may be relevant to understanding of the pathogenesis of AIDS which may in turn be helpful in designing appropriate therapeutic approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK040994-01
Application #
3241530
Study Section
Diabetes and Digestive and Kidney Diseases Special Grants Review Committee (DDK)
Project Start
1989-02-01
Project End
1992-01-31
Budget Start
1989-02-01
Budget End
1990-01-31
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Overall Medical
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Vijayan, E; Carraway, R; Leeman, S E et al. (1994) Physiological significance of neurotensin in pituitary glycoprotein hormone release as revealed by in vivo and in vitro studies with neurotensin antiserum. Neuroendocrinology 60:157-64
Karanth, S; Lyson, K; McCann, S M (1993) Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci U S A 90:3383-7
Lyson, K; McCann, S M (1993) Alpha-melanocyte-stimulating hormone abolishes IL-1- and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 58:191-5
Reznikov, A G; McCann, S M (1993) Effects of neuropeptide Y on gonadotropin and prolactin release in normal, castrated or flutamide-treated male rats. Neuroendocrinology 57:1148-54
Aguila, M C; Boggaram, V; McCann, S M (1993) Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels. Brain Res 625:213-8
Lyson, K; McCann, S M (1992) Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Neuroendocrinology 55:708-13
Karanth, S; Marubayashi, U; McCann, S M (1992) Influence of dopamine on the altered release of prolactin, luteinizing hormone, and follicle-stimulating hormone induced by interleukin-2 in vitro. Neuroendocrinology 56:871-80
Aguila, M C; Marubayashi, U; McCann, S M (1992) The effect of galanin on growth hormone-releasing factor and somatostatin release from median eminence fragments in vitro. Neuroendocrinology 56:889-94
Milenkovic, L; Lyson, K; Aguila, M C et al. (1992) Effect of thymosin alpha 1 on hypothalamic hormone release. Neuroendocrinology 56:674-9
Lyson, K; McCann, S M (1992) Induction of adrenocorticotropic hormone release by interleukin-6 in vivo and in vitro. Ann N Y Acad Sci 650:182-5

Showing the most recent 10 out of 15 publications